Broadcom's renewed Apple chip partnership is lifting semiconductor stocks broadly, with AVGO seen as the primary beneficiary of deepening custom silicon demand from the world's largest consumer tech company. The deal reinforces AVGO's position as a go-to ASIC partner and raises the floor on its AI-driven revenue trajectory heading into FY2026.
Broadcom's renewed Apple chip partnership is lifting semiconductor stocks broadly, with AVGO seen as the primary beneficiary of deepening custom silicon demand from the world's largest consumer tech company.
AVGO and AAPL are in focus as the Apple custom chip deal raises questions about how much incremental, durable revenue this adds to Broadcom's already-rich AI ASIC pipeline versus being a re-confirmation of an existing relationship priced into the stock.
If deal terms remain undisclosed or the partnership is framed as incremental rather than new, the stock could give back the pop; additionally, AVGO's stretched valuation post-AI rerating leaves little room for disappointment if broader semi sentiment deteriorates.
CoverageSource: Pluang · Published here MON, JUL 6 · 2:27 PM ET · the only report in this recordHow this is decided →
Broadcom's chip supply agreement with Apple is driving a broad lift in semiconductor names, with AVGO standing out as the clearest direct beneficiary. The news underscores Apple's continued push away from third-party merchant silicon toward custom in-house designs co-developed with trusted foundry and design partners — a trend that channels significant recurring revenue to Broadcom's custom ASIC business.
Broadcom reported FY2025 revenue of $63.9B, up nearly 24% year-over-year, with a 67.8% gross margin and $4.77 diluted EPS — metrics that already reflect robust AI and hyperscaler demand. Deepening the Apple relationship layers on a high-visibility, recurring contract win atop an already-accelerating revenue base. Apple itself, at $416.2B in revenue and 46.9% gross margins, has the financial firepower to commit to multiyear silicon partnerships at scale.
The second-order question is whether the Apple deal is additive to AVGO's AI XPU/ASIC pipeline or partially cannibalizes engineering bandwidth away from its cloud hyperscaler custom chip programs. Bulls will argue the two streams are largely parallel and that AVGO's design capacity has been scaling to meet demand. Bears will note that AVGO already trades at a premium multiple following its 2024 AI rerating, limiting near-term upside unless deal scope and financials are formally disclosed.
What to watch: any formal filing or earnings commentary quantifying the Apple deal's revenue contribution, AVGO's next earnings print, and whether the broader semi tape sustains the lift or fades without incremental confirmation.
AVGO's FY2025 revenue grew 24% YoY to $63.9B with 67.8% gross margins, already pricing in strong AI tailwinds — but a formalized Apple ASIC partnership adds a high-visibility, recurring revenue hook that the market may not have fully sized. Custom silicon TAM expansion with Apple as anchor customer supports a premium multiple defense and potentially drives estimate revisions higher into the next print.
The read above, as written. kept as written · closes shown from JUL 6 on
4-6 weeks, into next earnings. Follow to be told when one lands.
Price context does not establish that the story caused the move.
AVGO's 24% YoY revenue growth and dominant ASIC/XPU positioning mean an Apple anchor contract could drive meaningful upward estimate revisions, with the stock historically re-rating on each confirmed hyperscaler or OEM custom silicon win.
AVGO already trades at a premium multiple following its 2024 AI rerating, and without disclosed deal financials the Apple headline may simply be a re-confirmation of an existing commercial relationship rather than a genuinely new revenue catalyst.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →
This page is kept as it was written on Jul 6. Later coverage joins it only when the company and catalyst evidence match, and what the stock did is shown from licensed end-of-day closes — never re-graded, never backdated. The judgment is yours.